2-(4-((4-((5-Cyclopropyl-1H-pyrazol-3-yl)amino)-6-methylpyrimidin-2-yl)amino)phenyl)acetonitrile
CAS : 1216665-50-7
Ref. 3D-RYB66550
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- Benzeneacetonitrile, 4-[[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-methyl-2-pyrimidinyl]amino]-
- 4-[[4-[(5-Cyclopropyl-1H-pyrazol-3-yl)amino]-6-methyl-2-pyrimidinyl]amino]benzeneacetonitrile
2-(4-((4-((5-Cyclopropyl-1H-pyrazol-3-yl)amino)-6-methylpyrimidin-2-yl)amino)phenyl)acetonitrile is a test compound that inhibits bacterial RNA polymerase. This inhibition prevents transcription and replication, thereby preventing bacterial growth. 2-(4-((4-((5-Cyclopropyl-1H-pyrazol-3-yl)amino)-6--methylpyrimidin--2--yl)amino)phenyl)acetonitrile has been shown to be effective in retinitis pigmentosa and diabetes. It also has the potential to treat autoimmune diseases such as inflammatory diseases and neurodegenerative diseases.